Home R&D Page 12

R&D

Rare diseases

Challenges in place for therapy

By the 2020, drugs are expected to account for 19% of the total share of prescription drug sales

A monoclonal antibody to treat psoriasis

The first stem cell treatment approved in EU is made in...

First results on favipiravir against Ebola

New antitumoral study based on cell therapy

Phase 2 study for ralinepag in pulmonary hypertension

Multicentric study in Duchenne muscular dystrophy

Phase Ib study on prevention of C. difficilis infections

Positive Clinical Trial results for Antibody drugs conjugates

Ames test

Mutagenicity evaluation of 2-amino-4-thiazole acetic acid

1...111213...16Page 12 of 16
© © 2025 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151